A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis

Update Il y a 4 ans
Reference: NCT01223911

Woman and Man

Extract

This trial is conducted in Europe. The aim of this clinical trial is to investigate the safety, tolerability and pharmacokinetics (at which rate the drug is eliminated from the body) of NNC 151-0000-0000 in subjects with rheumatoid arthritis (RA).


Inclusion criteria

  • Inflammation ,Rheumatoid Arthritis


Links